Oumaima Aboubakr

Dr. Oumaima Aboubakr, a neuro-oncologist specializing in primary CNS lymphoma and epilepsy, shares vital insights on the surprising prevalence of seizures in these patients, noting that 25% experience them. She discusses how seizures can signal tumor activity and impact disease progression and prognosis. Aboubakr emphasizes the need for careful monitoring and adaptable treatment plans to manage seizure activity effectively. Her analysis urges healthcare professionals to deepen their understanding of seizure risks associated with CNS lymphoma.